Category: Globus MedicalSyndicate content

Globus Medical gains a bit on strong Q4 prelims

January 15, 2014 by Brad Perriello

Globus Medical shares are up this morning on preliminary 4th-quarter sales numbers that topped expectations and blew away the sluggish overall spinal implant market.

Globus Medical gains a bit on strong Q4 prelims

Globus Medical (NYSE:GMED) blew the doors off of the sluggish growth rate for the spinal implant market during the 4th quarter, topping Wall Street's expectations and sending share prices up today.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Globus Medical gets into robotic surgery with Excelsius Surgical acquisition

January 9, 2014 by Brad Perriello

Globus Medical gets into the robotic surgery arena with the acquisition of Excelsius Surgical and its positioning platform for spine and brain procedures.

Globus Medical gets into robotic surgery with Excelsius Surgical acquisition
Globus Medical gets into robotic surgery with Excelsius Surgical acquisition

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

J&J's Synthes wins round in spat with ex-sales rep

January 6, 2014 by Brad Perriello

Johnson & Johnson's Synthes subsidiary wins a round in its lawsuit against a former sales rep who jumped ship for rival Globus Medical, when a Pennsylvania appeals court rules that the lower court mistakenly applied California law in denying a Synthes bid for a preliminary injunction.

J&J's Synthes wins round in spat with ex-sales rep
J&J's Synthes wins round in spat with ex-sales rep

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Globus Medical gains on Q3 results, raised earnings guidance

November 1, 2013 by Brad Perriello

Globus Medical shares gain on strong 3rd-quarter results and increased earnings guidance.

Globus Medical gains on Q3 results, raised earnings guidance

Globus Medical (NYSE:GMED) shares gained this week after the medical device company reported strong 3rd-quarter results ahead of Wall Street's expectations and raised its earnings outlook for the rest of the year.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Globus Medical reveals FDA warning letter over MicroFuse putty

October 15, 2013 by Brad Perriello

Globus Medical says the FDA issued a warning letter over its MicroFuse bone-growth putty.

Globus Medical reveals FDA warning letter over MicroFuse putty

Globus Medical (NYSE:GMED) said the FDA issued a warning letter last month over its MicroFuse bone-growth putty, sending share prices down today on Wall Street.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

DePuy Synthes pursues more ex-sales reps, Globus

October 9, 2013 by Brad Perriello

Johnson & Johnson's DePuy Synthes subsidiary goes after a trio of ex-sales reps now working for rival Globus Medical in Texas.

DePuy Synthes pursues more Globus reps
DePuy Synthes pursues more Globus reps

Legal loss pushes Globus Medical's Q2 earnings down

August 5, 2013 by Brad Perriello

A $16 million patent infringement loss to Johnson & Johnson's DePuy-Synthes subsidiary pushes Globus Medical's 2nd-quarter earnings down, but share prices tick up as it beats Wall Street's expectations.

Legal loss pushes Globus Medical's Q2 earnings down

Globus Medical (NYSE:GMED) shares rose more than 2% last week despite a 61% 2nd-quarter profit slide after the medical device company reported earnings above Wall Street's forecast and confirmed its outlook for the rest of the year.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp